Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis - Contacts and Locations

Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

This study has been completed.
Information provided by Office of Rare Diseases (ORD)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00014755

Locations


United States, California
	City of Hope National Medical Center
	Duarte, California, United States, 91010

United States, Colorado
	University of Colorado Cancer Center
	Denver, Colorado, United States, 80262

United States, Missouri
	Washington University Barnard Cancer Center
	Saint Louis, Missouri, United States, 63110

United States, Nebraska
	University of Nebraska Medical Center
	Omaha, Nebraska, United States, 68198-3330

United States, North Carolina
	Duke University Medical Center
	Durham, North Carolina, United States, 27710

United States, Washington
	Fred Hutchinson Cancer Research Center
	Seattle, Washington, United States, 98109

Sponsors and Collaborators

Fred Hutchinson Cancer Research Center

Investigators


Study Chair:	Richard Nash	Fred Hutchinson Cancer Research Center